OSHA SearchOSHA records by employer

Alvogen Group Inc.: OSHA inspections and violations

Pine Brook, New Jersey · Pharmaceutical Preparation Manufacturing · NAICS 325412

1inspections
2citation items
$3,500current penalties
Jan 21, 2020last inspection

OSHA inspectors have visited Alvogen Group Inc. in New Jersey one time.

It opened on Jan 21, 2020 as a planned inspection, in Pine Brook.

In all, OSHA issued 2 citation items: 2 serious.

The proposed penalties came to $5,783; today they stand at $3,500, 39% less.

The rule cited most here is 1910.134 (respiratory protection), 2 times.

Among manufacturing employers, the typical cited inspection since 2015 ends with a $4,500 penalty. Alvogen Group Inc. averages $3,500 across 1 cited inspection.

Alvogen Group Inc.: OSHA citation items per year, 2020 to 2020
Citation items per year, by inspection date.

New Jersey · latest 90 days of OSHA records

264employers cited

Get notified the morning OSHA posts each new citation in New Jersey: the employer, the site address, the rules broken and the penalty.

See who gets cited next

Latest cited in New Jersey

Checking a subcontractor, a client or your own company? Watch Alvogen Group Inc. and get notified the morning OSHA posts a new citation for it.

Watch this company

Inspection history

Inspection 344568704 OPENED JAN 21, 2020Closed

Planned · Partial · Health · 30 employees at the site · Closed Sep 30, 2025

10 Bloomfield Ave Building B, Pine Brook, NJ 07058 · Pharmaceutical Preparation Manufacturing · OSHA's record · Phone and website on Google Maps

Citation and ruleTypeProposedCurrentIssuedStatus
Citation 1, item 1a
29 CFR 1910.134(c)(1) · Respiratory protection
Serious$5,783$3,500Jun 2, 2020Final
Citation 1, item 1b
29 CFR 1910.134(f)(2) · Respiratory protection
Serious$0$0Jun 2, 2020Final

The rules behind these citations

Current text from the Code of Federal Regulations. Some citations were issued under older wording.

29 CFR 1910.134 · Respiratory protection

29 CFR 1910.134(c)(1)

(1) The test instrument must have an effective audio-warning device, or a visual-warning device in the form of a screen tracing, that indicates when the test subject fails to hold his or her breath during the test. The test must be terminated and restarted from the beginning when the test subject fails to hold his or her breath during the test. The test subject then may be refitted and retested.

29 CFR 1910.134(f)(2)

(2) Deep breathing. In a normal standing position, the subject shall breathe slowly and deeply, taking caution so as not to hyperventilate.

Other pharmaceutical preparation manufacturing employers in New Jersey

Alert subscribers get notified of each newly cited employer in New Jersey the morning it is posted. See the alert plans.

Source: U.S. Department of Labor, OSHA enforcement data. A citation is OSHA's allegation; employers can contest it, and the status column shows where each item stands. Something wrong on this page? Tell us.